Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2100043320Phase 4Recruiting
Phase 4, randomised trial of alfentanil in Maxillofacial Disorders and Emergence agitation (EA) (4 arms), sponsored by The Affiliated Stomatological Hospital of Chongqing Medical University. Primary endpoints: Emergence agitation and Recovery time. Started Oct 2020; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2100043320.